Hourglass Capital LLC Has $8.79 Million Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Hourglass Capital LLC reduced its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 4.8% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 21,617 shares of the company’s stock after selling 1,090 shares during the quarter. HCA Healthcare accounts for approximately 2.4% of Hourglass Capital LLC’s holdings, making the stock its 6th biggest position. Hourglass Capital LLC’s holdings in HCA Healthcare were worth $8,786,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in the company. Vanguard Group Inc. grew its stake in shares of HCA Healthcare by 0.4% during the 1st quarter. Vanguard Group Inc. now owns 16,989,683 shares of the company’s stock valued at $5,666,569,000 after purchasing an additional 60,304 shares during the period. Capital World Investors lifted its position in shares of HCA Healthcare by 57.5% during the 1st quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock valued at $931,342,000 after buying an additional 1,019,750 shares in the last quarter. Darsana Capital Partners LP lifted its position in shares of HCA Healthcare by 53.3% during the 2nd quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock valued at $369,472,000 after buying an additional 400,000 shares in the last quarter. TD Asset Management Inc lifted its position in shares of HCA Healthcare by 2.7% during the 2nd quarter. TD Asset Management Inc now owns 741,130 shares of the company’s stock valued at $238,110,000 after buying an additional 19,812 shares in the last quarter. Finally, Epoch Investment Partners Inc. lifted its position in shares of HCA Healthcare by 16.4% during the 2nd quarter. Epoch Investment Partners Inc. now owns 631,854 shares of the company’s stock valued at $203,002,000 after buying an additional 88,948 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Stock Performance

NYSE:HCA opened at $349.32 on Thursday. The stock’s fifty day moving average is $387.95 and its 200 day moving average is $357.16. HCA Healthcare, Inc. has a fifty-two week low of $233.23 and a fifty-two week high of $417.14. The firm has a market capitalization of $88.48 billion, a PE ratio of 15.69, a PEG ratio of 1.35 and a beta of 1.68. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be issued a dividend of $0.66 per share. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 annualized dividend and a yield of 0.76%. HCA Healthcare’s payout ratio is presently 11.85%.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 1.60% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on HCA shares. Wells Fargo & Company lifted their price objective on HCA Healthcare from $395.00 to $400.00 and gave the company an “equal weight” rating in a research report on Wednesday, November 6th. Oppenheimer upped their price target on HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research note on Monday, October 28th. Truist Financial upped their price target on HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a research note on Monday, August 19th. Wolfe Research upgraded HCA Healthcare to a “strong-buy” rating in a research note on Thursday, August 29th. Finally, Morgan Stanley assumed coverage on HCA Healthcare in a research note on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price target for the company. Five analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $385.00.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.